# reload+after+2024-01-22 23:47:37.571428
address1§IDA Business Park
city§Bray
zip§A98 H5C8
country§Ireland
phone§353 1 276 9800
fax§353 1 276 9888
website§https://www.trinitybiotech.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
fullTimeEmployees§398
companyOfficers§[{'maxAge': 1, 'name': 'Mr. John  Gillard', 'age': 42, 'title': 'President, CEO, Company Secretary & Director', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 863000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Mr. Ronan  O'Caoimh", 'age': 67, 'title': 'Founder & Director', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 340000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. James  Walsh Ph.D.', 'age': 65, 'title': 'Executive Director of Business Development & Executive Director', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 20000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Des  Fitzgerald', 'title': 'Interim Chief Financial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Simon  Dunne', 'age': 49, 'title': 'Chief Accounting Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Gary  Keating Ph.D.', 'age': 50, 'title': 'Chief Technology Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Eibhlin  Kelly', 'age': 39, 'title': 'Chief Information Officer', 'yearBorn': 1984, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Colm  Molloy', 'age': 52, 'title': 'Group Director of Human Resources & Culture', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
exDividendDate§1433462400
payoutRatio§0.0
fiveYearAvgDividendYield§1.19
beta§1.338
priceToSalesTrailing12Months§0.27963468
currency§USD
dateShortInterest§1702598400
forwardEps§-0.3
pegRatio§-0.05
exchange§NMS
quoteType§EQUITY
shortName§Trinity Biotech plc
longName§Trinity Biotech plc
firstTradeDateEpochUtc§719674200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f11095f5-a45d-3fd0-867a-c30f29ce8486
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.0
targetLowPrice§3.0
targetMeanPrice§3.0
targetMedianPrice§3.0
recommendationKey§none
numberOfAnalystOpinions§1
quickRatio§2.055
grossMargins§0.29121
ebitdaMargins§-0.20392
trailingPegRatio§None
